Valor202020212022202320242025TTMGastos comerciales, generales y administrativos5.36 B6.43 B6.46 B7.13 B7.68 B8.65 B8.65 BInvestigación y desarrollo984 M1.24 B1.45 B1.39 B1.47 B1.62 B1.62 BBeneficio operativo2.22 B2.58 B2.84 B3.89 B3.69 B4.89 B4.89 BTotal de ingresos no operativos-269 M-303 M-158 M-215 M-197 M232 M232 MGastos por intereses, netos de intereses capitalizados315 M337 M337 M356 M396 M607 M582 MIngresos no operativos, una vez deducidos los gastos por intereses-584 M-640 M-495 M-571 M-593 M-375 M-350 MIngresos/gastos extraordinarios———————Beneficio antes de impuestos1.95 B2.28 B2.68 B3.67 B3.49 B4.51 B4.51 BParticipación en los beneficios———————Impuestos355 M287 M325 M508 M499 M1.27 B1.27 BParticipación minoritaria———————Otros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.25 BOperaciones suspendidas———————Beneficio neto1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.25 BAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.25 BBeneficio básico por acción4.265.296.238.347.868.498.49Beneficio por acción diluido4.25.216.178.257.768.48.4Número medio de acciones ordinarias375.5 M377 M378.2 M379.6 M381 M382.2 M1.53 BAcciones diluidas380.3 M382.3 M382.2 M383.7 M385.6 M386.5 M1.55 BEBITDA3.3 B3.86 B4.12 B5.23 B5.12 B6.46 B6.46 BEBIT2.22 B2.58 B2.84 B3.89 B3.69 B4.89 B4.89 BCosto de los ingresos5.29 B6.14 B6.87 B7.44 B8.15 B9.05 B9.05 BOtros costes de producción———————Amortización y depreciación (flujo de caja)1.08 B1.27 B1.28 B1.34 B1.43 B1.57 B1.57 B
Stryker Corporation
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000.